Keyphrases
Lipids
100%
Mass Spectrometry Imaging
100%
Lipid Signature
100%
Hepatic Lipid
100%
Leishmania Donovani
100%
Mouse Liver
57%
Nave
42%
Liver
42%
Infected Mice
42%
Spatial Resolution
28%
Granuloma
28%
Phospholipids
28%
MALDI Mass Spectrometry Imaging
28%
Structural Identification
28%
Hepatic Granuloma
28%
C57BL
14%
Lipid Metabolism
14%
Region of Interest
14%
Spatial-temporal
14%
Infectious Diseases
14%
Heterogeneous Distribution
14%
Spatial Data
14%
Liver Tissue
14%
Tissue Level
14%
Lipid Modification
14%
Arachidonic Acid
14%
Negative Ion Mode
14%
Spatial Analysis
14%
Infection Model
14%
Lipid Analysis
14%
Post-infection
14%
Local Site
14%
Inflammatory Cascade
14%
Data-driven Analysis
14%
Leishmaniasis
14%
Oxylipins
14%
Identification Analysis
14%
Specific Lipids
14%
Granulomatous Inflammation
14%
Infection Site
14%
Inflammatory Microenvironment
14%
Bruker
14%
Phosphatidylglycerol
14%
Transverse Section
14%
Bulk Tissue
14%
Visceral Leishmaniasis
14%
Thermo
14%
Parenchymal Tissue
14%
Lipid Abundance
14%
Orbitrap Elite
14%
Preclinical Animal Models
14%
Fold Increase
14%
Histopathological Features
14%
Hepatic Lipid Profile
14%
Immunology and Microbiology
Lipid Liver Level
100%
Imaging Mass Spectrometry
100%
Leishmaniasis
100%
Granuloma
66%
Parenchyma
50%
Matrix-Assisted Laser Desorption-Ionization
33%
Leishmania donovani
33%
C57BL 6 Mouse
16%
Lipid Metabolism
16%
Mouse Model
16%
Infectious Disease
16%
Lipid Composition
16%
Experimental Mouse
16%
Precursor
16%
Liver Tissue
16%
Tissue Level
16%
Volume
16%
Visceral Leishmaniasis
16%
INIS
liver
100%
mass spectrometry
100%
lipids
100%
mice
50%
granulomas
28%
tissues
21%
inflammation
21%
spatial resolution
14%
phospholipids
14%
data
7%
levels
7%
regulations
7%
comparative evaluations
7%
pathology
7%
maps
7%
metabolism
7%
pathogenesis
7%
precursor
7%
distribution
7%
abundance
7%
infectious diseases
7%
host
7%
arachidonic acid
7%
parasites
7%